Biotechnology News and Research RSS Feed - Biotechnology News and Research

Selonterra publishes article on novel APOE4 mechanism linked to Alzheimer’s disease

Selonterra publishes article on novel APOE4 mechanism linked to Alzheimer’s disease

Selonterra LLC, a biotechnology company discovering therapies for Alzheimer’s disease and Parkinson’s disease announced the publication of the article “Identification of a Nuclear Respiratory Factor 1 Recognition Motif in the Apolipoprotein E Variant APOE4 linked to Alzheimer’s Disease” in Scientific Reports, a peer-reviewed journal of the Nature Publishing Group. [More]
Eosera introduces new solution for earwax impaction

Eosera introduces new solution for earwax impaction

EOSERA™, Inc. , a Dallas-based biotechnology innovator founded by two veterans of the pharmaceutical industry, today announced the introduction of Earwax MD—the ideal solution for those who dread the time, worry, and expense of a doctor’s visit to clear their ears of burdensome earwax impaction. [More]
MRI as a new tool for MS, with the help of Siemens Healthineers and Biogen

MRI as a new tool for MS, with the help of Siemens Healthineers and Biogen

Siemens Healthineers and Biogen announced today that the companies plan to jointly develop Magnetic Resonance Imaging (MRI) applications with the intent of quantifying key markers of multiple sclerosis (MS) disease activity and progression. Biogen is a leading biotechnology company with a deep focus on neurological and autoimmune conditions, which for two decades has been at the forefront of delivering therapies to MS patients. [More]
Fraunhofer scientists develop new method to irradiate pathogens using low-energy-electrons

Fraunhofer scientists develop new method to irradiate pathogens using low-energy-electrons

Many vaccines contain viruses that are inactivated to prevent them from harming recipients. [More]
Study finds link between obesity-related disease and epigenetic modifications

Study finds link between obesity-related disease and epigenetic modifications

Obesity has been linked to "letter" changes at many different sites in the genome, yet these differences do not fully explain the variation in people's body mass index (BMI) or why some overweight people develop health complications while others don't. [More]
Georgia State University, GeoVax join forces to advance development of Hepatitis B therapeutic vaccine

Georgia State University, GeoVax join forces to advance development of Hepatitis B therapeutic vaccine

The Georgia State University Research Foundation has entered into a research collaboration agreement with GeoVax Labs, Inc., a Georgia-based biotechnology company developing human vaccines, to advance development of a therapeutic vaccine for treatment of chronic Hepatitis B infections. [More]
Chemotherapy-induced senescent cells promote side effects and cancer relapse

Chemotherapy-induced senescent cells promote side effects and cancer relapse

Standard chemotherapy is a blunt force instrument against cancer - and it's a rare cancer patient who escapes debilitating side effects from systemic treatments that mostly affect dividing cells, both malignant and healthy, throughout the body. [More]
Ludwig study uncovers ancient cellular response that underlies spread of aggressive skin cancer

Ludwig study uncovers ancient cellular response that underlies spread of aggressive skin cancer

Each day, more than 1,600 people die from cancer in the US, and 450 in the UK, mostly because the disease has spread beyond a stage when surgery is an effective cure and has become resistant to therapy. Despite decades of research, understanding why cancer cells become invasive has remained shrouded in mystery. [More]
Harvard scientists discuss promise and peril of emerging IVG technique

Harvard scientists discuss promise and peril of emerging IVG technique

In vitro fertilization has transformed reproductive medicine and sparked a number of therapeutic and diagnostic breakthroughs. [More]
NCI launches new drug formulary to help expedite use of agents in clinical studies

NCI launches new drug formulary to help expedite use of agents in clinical studies

The National Cancer Institute today launched a new drug formulary (the "NCI Formulary") that will enable investigators at NCI-designated Cancer Centers to have quicker access to approved and investigational agents for use in preclinical studies and cancer clinical trials. [More]
ATA releases new guidelines for diagnosis, treatment of thyroid disease during pregnancy and postpartum

ATA releases new guidelines for diagnosis, treatment of thyroid disease during pregnancy and postpartum

New evidence-based recommendations from the American Thyroid Association provide guidance to clinicians in diagnosing and managing thyroid disease during pregnancy and the postpartum period. [More]
Researchers provide clues to how mcr-1 gene protects bacteria from 'last resort' antibiotic

Researchers provide clues to how mcr-1 gene protects bacteria from 'last resort' antibiotic

An international research team, led by the University of Bristol, has provided the first clues to understand how the mcr-1 gene protects bacteria from colistin - a 'last resort' antibiotic used to treat life-threatening bacterial infections that do not respond to other treatment options. [More]
Mediterranean diet may help provide long-term protection to the brain

Mediterranean diet may help provide long-term protection to the brain

A new study shows that older people who followed a Mediterranean diet retained more brain volume over a three-year period than those who did not follow the diet as closely. [More]
Scientists develop technique to produce antibiotic synthetic spider silk

Scientists develop technique to produce antibiotic synthetic spider silk

A chance meeting between a spider expert and a chemist has led to the development of antibiotic synthetic spider silk. [More]
Powerful version of anti-inflammatory molecule may help protect vision in diabetic retinopathy

Powerful version of anti-inflammatory molecule may help protect vision in diabetic retinopathy

A more powerful version of an anti-inflammatory molecule already circulating in our blood may help protect our vision in the face of diabetes. [More]
AAV-based gene therapy to treat liver disorders advances into human testing

AAV-based gene therapy to treat liver disorders advances into human testing

Liver-directed gene therapy delivered using adeno-associated viral (AAV) vectors to treat diseases such as hemophilia have advanced into human testing. [More]
Scripps physician first to treat heart attack patients with supersaturated oxygen therapy

Scripps physician first to treat heart attack patients with supersaturated oxygen therapy

A physician at Scripps Health's Prebys Cardiovascular Institute has become the first in the Western United States to treat heart attack patients with a new supersaturated oxygen (SSO2) system in an attempt to reduce permanent damage to their heart muscle. [More]
Specific gene pathway appears to regulate growth, structure, and organization of cerebral cortex

Specific gene pathway appears to regulate growth, structure, and organization of cerebral cortex

One of the most significant ways in which the human brain is unique is the size and structure of the cerebral cortex. But what drives the growth of the human cortex, likely the foundation for our unique intellectual abilities? [More]
Nexmos, Base Pair Biotechnologies create new class of DNA-aptamer based oxidation inhibitors

Nexmos, Base Pair Biotechnologies create new class of DNA-aptamer based oxidation inhibitors

Base Pair Biotechnologies, Inc., The Aptamer Discovery Company, and Nexmos, Inc., the Aptamer Application R&D Company, announce the creation of a new class of DNA-aptamer based oxidation inhibitors. [More]
Studies in non-human primates provide more predictive results in genetic causes of blindness

Studies in non-human primates provide more predictive results in genetic causes of blindness

Many gene therapy-based approaches are in development to combat genetic and other causes of blindness and vision loss, and much can be learned about the safety and effectiveness of these promising new therapies by studying them first in non-human primates before initiating clinical trials, as shown by the results of a study published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. [More]
Advertisement
Advertisement